The global Alzheimer's Disease Therapeutics and Diagnostics market is projected to grow from US$ 3680.4 million in 2024 to US$ 4024.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.5% during the forecast period.

Alzheimer's Disease Therapeutics and Diagnostics Market

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Market Analysis and Insights: Global Alzheimer's Disease Therapeutics and Diagnostics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Alzheimer's Disease Therapeutics and Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Alzheimer's Disease Therapeutics and Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Alzheimer's Disease Therapeutics and Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alzheimer's Disease Therapeutics and Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Alzheimer's Disease Therapeutics and Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Alzheimer's Disease Therapeutics and Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Alzheimer's Disease Therapeutics and Diagnostics Market Report

Report Metric	Details
Report Name	Alzheimer's Disease Therapeutics and Diagnostics Market
Accounted market size in 2024	US$ 3680.4 in million
Forecasted market size in 2030	US$ 4024.3 million
CAGR	1.5
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Biomarkers Cholinesterase inhibitors NMDA receptor antagonists Brain imaging Blood tests
Segment by Application	Drugs Market Diagnostics Market
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Namenda, Aricept, Exelon, Solanezumab, Gantenerumab, Verubecestat, Pfizer, Eisai, Actavis, Lundbeck, Daiichi Sankyo, Novartis, TauRx
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Alzheimer's Disease Therapeutics and Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease Therapeutics and Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alzheimer's Disease Therapeutics and Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Alzheimer's Disease Therapeutics and Diagnostics Market growing?

Ans: The Alzheimer's Disease Therapeutics and Diagnostics Market witnessing a CAGR of 1.5 during the forecast period 2024-2030.

What is the Alzheimer's Disease Therapeutics and Diagnostics Market size in 2030?

Ans: The Alzheimer's Disease Therapeutics and Diagnostics Market size in 2030 will be US$ 4024.3 million.

Who are the main players in the Alzheimer's Disease Therapeutics and Diagnostics Market report?

Ans: The main players in the Alzheimer's Disease Therapeutics and Diagnostics Market are Namenda, Aricept, Exelon, Solanezumab, Gantenerumab, Verubecestat, Pfizer, Eisai, Actavis, Lundbeck, Daiichi Sankyo, Novartis, TauRx

What are the Application segmentation covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report?

Ans: The Applications covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report are Drugs Market, Diagnostics Market

What are the Type segmentation covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report?

Ans: The Types covered in the Alzheimer's Disease Therapeutics and Diagnostics Market report are Biomarkers, Cholinesterase inhibitors, NMDA receptor antagonists, Brain imaging, Blood tests

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Biomarkers

1.2.3 Cholinesterase inhibitors

1.2.4 NMDA receptor antagonists

1.2.5 Brain imaging

1.2.6 Blood tests

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Drugs Market

1.3.3 Diagnostics Market

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Perspective (2019-2030)

2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Growth Trends by Region

2.2.1 Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Alzheimer's Disease Therapeutics and Diagnostics Market Dynamics

2.3.1 Alzheimer's Disease Therapeutics and Diagnostics Industry Trends

2.3.2 Alzheimer's Disease Therapeutics and Diagnostics Market Drivers

2.3.3 Alzheimer's Disease Therapeutics and Diagnostics Market Challenges

2.3.4 Alzheimer's Disease Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Alzheimer's Disease Therapeutics and Diagnostics by Players

3.1.1 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Players (2019-2024)

3.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Alzheimer's Disease Therapeutics and Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio

3.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2023

3.5 Global Key Players of Alzheimer's Disease Therapeutics and Diagnostics Head office and Area Served

3.6 Global Key Players of Alzheimer's Disease Therapeutics and Diagnostics, Product and Application

3.7 Global Key Players of Alzheimer's Disease Therapeutics and Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Type

4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)

5 Alzheimer's Disease Therapeutics and Diagnostics Breakdown Data by Application

5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

6.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type

6.2.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024)

6.2.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030)

6.2.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

6.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application

6.3.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024)

6.3.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030)

6.3.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

6.4 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country

6.4.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)

6.4.3 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

7.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type

7.2.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024)

7.2.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030)

7.2.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application

7.3.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024)

7.3.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030)

7.3.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

7.4 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country

7.4.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)

7.4.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

8.2 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type

8.2.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024)

8.2.2 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030)

8.2.3 China Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

8.3 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application

8.3.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024)

8.3.2 China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030)

8.3.3 China Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

9.2 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type

9.2.1 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024)

9.2.2 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030)

9.2.3 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

9.3 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application

9.3.1 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024)

9.3.2 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030)

9.3.3 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

9.4 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region

9.4.1 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2019-2024)

9.4.3 Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Namenda

11.1.1 Namenda Company Details

11.1.2 Namenda Business Overview

11.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.1.4 Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.1.5 Namenda Recent Developments

11.2 Aricept

11.2.1 Aricept Company Details

11.2.2 Aricept Business Overview

11.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.2.4 Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.2.5 Aricept Recent Developments

11.3 Exelon

11.3.1 Exelon Company Details

11.3.2 Exelon Business Overview

11.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.3.4 Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.3.5 Exelon Recent Developments

11.4 Solanezumab

11.4.1 Solanezumab Company Details

11.4.2 Solanezumab Business Overview

11.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.4.4 Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.4.5 Solanezumab Recent Developments

11.5 Gantenerumab

11.5.1 Gantenerumab Company Details

11.5.2 Gantenerumab Business Overview

11.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.5.4 Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.5.5 Gantenerumab Recent Developments

11.6 Verubecestat

11.6.1 Verubecestat Company Details

11.6.2 Verubecestat Business Overview

11.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.6.4 Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.6.5 Verubecestat Recent Developments

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.7.4 Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.7.5 Pfizer Recent Developments

11.8 Eisai

11.8.1 Eisai Company Details

11.8.2 Eisai Business Overview

11.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.8.4 Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.8.5 Eisai Recent Developments

11.9 Actavis

11.9.1 Actavis Company Details

11.9.2 Actavis Business Overview

11.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.9.4 Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.9.5 Actavis Recent Developments

11.10 Lundbeck

11.10.1 Lundbeck Company Details

11.10.2 Lundbeck Business Overview

11.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.10.4 Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.10.5 Lundbeck Recent Developments

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Details

11.11.2 Daiichi Sankyo Business Overview

11.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.11.4 Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.11.5 Daiichi Sankyo Recent Developments

11.12 Novartis

11.12.1 Novartis Company Details

11.12.2 Novartis Business Overview

11.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.12.4 Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.12.5 Novartis Recent Developments

11.13 TauRx

11.13.1 TauRx Company Details

11.13.2 TauRx Business Overview

11.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Introduction

11.13.4 TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

11.13.5 TauRx Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Biomarkers

Table 3. Key Players of Cholinesterase inhibitors

Table 4. Key Players of NMDA receptor antagonists

Table 5. Key Players of Brain imaging

Table 6. Key Players of Blood tests

Table 7. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2019-2024)

Table 11. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2025-2030)

Table 13. Alzheimer's Disease Therapeutics and Diagnostics Market Trends

Table 14. Alzheimer's Disease Therapeutics and Diagnostics Market Drivers

Table 15. Alzheimer's Disease Therapeutics and Diagnostics Market Challenges

Table 16. Alzheimer's Disease Therapeutics and Diagnostics Market Restraints

Table 17. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players (2019-2024)

Table 19. Global Top Alzheimer's Disease Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2023)

Table 20. Global Alzheimer's Disease Therapeutics and Diagnostics Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Alzheimer's Disease Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Alzheimer's Disease Therapeutics and Diagnostics, Headquarters and Area Served

Table 23. Global Key Players of Alzheimer's Disease Therapeutics and Diagnostics, Product and Application

Table 24. Global Key Players of Alzheimer's Disease Therapeutics and Diagnostics, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)

Table 28. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)

Table 30. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Application (2019-2024)

Table 32. Global Alzheimer's Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Application (2025-2030)

Table 34. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Alzheimer's Disease Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Alzheimer's Disease Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Alzheimer's Disease Therapeutics and Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 66. Namenda Company Details

Table 67. Namenda Business Overview

Table 68. Namenda Alzheimer's Disease Therapeutics and Diagnostics Product

Table 69. Namenda Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 70. Namenda Recent Developments

Table 71. Aricept Company Details

Table 72. Aricept Business Overview

Table 73. Aricept Alzheimer's Disease Therapeutics and Diagnostics Product

Table 74. Aricept Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 75. Aricept Recent Developments

Table 76. Exelon Company Details

Table 77. Exelon Business Overview

Table 78. Exelon Alzheimer's Disease Therapeutics and Diagnostics Product

Table 79. Exelon Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 80. Exelon Recent Developments

Table 81. Solanezumab Company Details

Table 82. Solanezumab Business Overview

Table 83. Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product

Table 84. Solanezumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 85. Solanezumab Recent Developments

Table 86. Gantenerumab Company Details

Table 87. Gantenerumab Business Overview

Table 88. Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product

Table 89. Gantenerumab Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 90. Gantenerumab Recent Developments

Table 91. Verubecestat Company Details

Table 92. Verubecestat Business Overview

Table 93. Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product

Table 94. Verubecestat Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 95. Verubecestat Recent Developments

Table 96. Pfizer Company Details

Table 97. Pfizer Business Overview

Table 98. Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product

Table 99. Pfizer Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 100. Pfizer Recent Developments

Table 101. Eisai Company Details

Table 102. Eisai Business Overview

Table 103. Eisai Alzheimer's Disease Therapeutics and Diagnostics Product

Table 104. Eisai Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 105. Eisai Recent Developments

Table 106. Actavis Company Details

Table 107. Actavis Business Overview

Table 108. Actavis Alzheimer's Disease Therapeutics and Diagnostics Product

Table 109. Actavis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 110. Actavis Recent Developments

Table 111. Lundbeck Company Details

Table 112. Lundbeck Business Overview

Table 113. Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product

Table 114. Lundbeck Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 115. Lundbeck Recent Developments

Table 116. Daiichi Sankyo Company Details

Table 117. Daiichi Sankyo Business Overview

Table 118. Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product

Table 119. Daiichi Sankyo Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 120. Daiichi Sankyo Recent Developments

Table 121. Novartis Company Details

Table 122. Novartis Business Overview

Table 123. Novartis Alzheimer's Disease Therapeutics and Diagnostics Product

Table 124. Novartis Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 125. Novartis Recent Developments

Table 126. TauRx Company Details

Table 127. TauRx Business Overview

Table 128. TauRx Alzheimer's Disease Therapeutics and Diagnostics Product

Table 129. TauRx Revenue in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 130. TauRx Recent Developments

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Biomarkers Features

Figure 4. Cholinesterase inhibitors Features

Figure 5. NMDA receptor antagonists Features

Figure 6. Brain imaging Features

Figure 7. Blood tests Features

Figure 8. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030

Figure 10. Drugs Market Case Studies

Figure 11. Diagnostics Market Case Studies

Figure 12. Alzheimer's Disease Therapeutics and Diagnostics Report Years Considered

Figure 13. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Alzheimer's Disease Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030

Figure 16. Global Alzheimer's Disease Therapeutics and Diagnostics Market Share by Players in 2023

Figure 17. Global Top Alzheimer's Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Therapeutics and Diagnostics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Alzheimer's Disease Therapeutics and Diagnostics Revenue in 2023

Figure 19. North America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 21. North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 22. North America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 23. United States Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 27. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 28. Europe Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 29. Germany Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 37. China Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 38. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 40. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 41. Asia Alzheimer's Disease Therapeutics and Diagnostics Market Share by Region (2019-2030)

Figure 42. Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Alzheimer's Disease Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 52. Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Namenda Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 59. Aricept Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 60. Exelon Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 61. Solanezumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 62. Gantenerumab Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 63. Verubecestat Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 64. Pfizer Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 65. Eisai Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 66. Actavis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 67. Lundbeck Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 68. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 69. Novartis Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 70. TauRx Revenue Growth Rate in Alzheimer's Disease Therapeutics and Diagnostics Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alzheimer s Disease Treatments Market Research Report 2024

Global Alzheimer Treatment Drug Market Research Report 2025

Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030

Global Blood based Detection Kit for Early Diagnosis of Alzheimer s Disease Market Research Report 2024

Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Disease Blood Test Kit Market Research Report 2024

Global Alzheimer s Disease Diagnosis Market Research Report 2024

Global Neurodegenerative Disease Market Insights Forecast to 2030

Alzheimer s Disease Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Amnestic Disorders Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurodegenerative Disease Treatment Market Research Report 2024

Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for Alzheimer s Disease Market Research Report 2024

Global Alzheimer s Disease Biomarker Market Research Report 2024

Alzheimer Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alzheimer s Treatment Drug Market Research Report 2024

Global Parkinson s Disease Treatment Market Insights Forecast to 2030

Global Alzheimer s Clinical Treatment Drug Market Research Report 2025

Global Neurodegenerative Disorder Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions